Page last updated: 2024-08-24

cidofovir anhydrous and Mycoses

cidofovir anhydrous has been researched along with Mycoses in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bandt, D; Bornhäuser, M; Ehninger, G; Freiberg-Richter, J; Geissler, G; Helwig, A; Platzbecker, U; Plettig, R; Rethwilm, A; Schuler, U; Thiede, C	1

Other Studies

1 other study(ies) available for cidofovir anhydrous and Mycoses

Article	Year
Successful preemptive cidofovir treatment for CMV antigenemia after dose-reduced conditioning and allogeneic blood stem cell transplantation. Transplantation, 2001, Apr-15, Volume: 71, Issue:7 Topics: Adult; Antigens, Viral; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Dose-Response Relationship, Drug; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Middle Aged; Mycoses; Myeloablative Agonists; Organophosphonates; Organophosphorus Compounds; Phosphoproteins; Preventive Medicine; Prospective Studies; Transplantation Conditioning; Viral Matrix Proteins	2001

Article

Year

Successful preemptive cidofovir treatment for CMV antigenemia after dose-reduced conditioning and allogeneic blood stem cell transplantation.

Transplantation, 2001, Apr-15, Volume: 71, Issue:7

Topics: Adult; Antigens, Viral; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Dose-Response Relationship, Drug; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Middle Aged; Mycoses; Myeloablative Agonists; Organophosphonates; Organophosphorus Compounds; Phosphoproteins; Preventive Medicine; Prospective Studies; Transplantation Conditioning; Viral Matrix Proteins

2001